Skip to main content
. Author manuscript; available in PMC: 2018 Feb 1.
Published in final edited form as: Atherosclerosis. 2016 Dec 15;257:38–46. doi: 10.1016/j.atherosclerosis.2016.12.014

Fig. 6. P2Y2R inhibits Runx2-activation of the osteocalcin promoter.

Fig. 6

P2Y2R-null VSMC were transfected with an osteocalcin promoter luciferase reporter gene, an internal control pRL-TK plasmid, a Runx2 expression plasmid, and a full length P2Y2R expression plasmid as indicated. Lysates were harvested 48 h after transfection and were normalized to the expression of the pRL-TK plasmid. Results are presented as the mean ± SD of triplicates of cells and are representative of three independent experiments. ***p<0.001.